M. Andrew

Can Radiation Enhance Response to Checkpoint Inhibition in Advanced-Stage NSCLC? A Case Series and Review of the Literature

E. B. Butler, S. Chiang, H. Preti, 2019 .

Endogenous production of IL-1B by breast cancer cells drives metastasis and colonisation of the bone microenvironment.

W. Gregory, P. Heath, Janet E Brown, 2020 .

A second generation KSP inhibitor, SB-743921, is a highly potent and active therapeutic in preclinical models of cancer

K. Wood, J. Jackson, A. Gilmartin, 2006 .